Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial

Ultra-low-dose 0.005 % estriol vaginal gel is safe and effective in preventing recurrent urinary tract infections in postmenopausal women with genitourinary syndrome of menopause, reducing the incidence and potentially decreasing the susceptibility to urogenital infections by improving vaginal pH. Study registration N°: 2018-001481-42. Date of registration: 09-04-2018.

Authors

Institutions

Publication Details

Journal
Maturitas
Published
2024-09-28
DOI
https://doi.org/10.1016/j.maturitas.2024.108128
Citations
5
Primary Topic
Urinary Tract Infections Management
Type
article
Field-Weighted Citation Impact
1.93
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial

Juan Ignacio Martínez‐Salamanca, Eva García Aguilar, Milagros González Béjar, Amelia Rodríguez Mariblanca et al.
5 citations
Maturitas
Urinary Tract Infections Management
1.93
article

Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial

Juan Ignacio Martínez‐Salamanca, Eva García Aguilar, Milagros González Béjar, Amelia Rodríguez Mariblanca, Javier Rosado Martín, Lourdes Palomo Alameda, M Pilar Diz Morales, Laura Noguera Vera, José Ignacio Pardo González de Quevedo, Nuno Muiños Fernández, Ana Doyle Sanchez, Susana Duce Tello, Alejandra Rabanal Carrera
article en
5 citations

Abstract

Ultra-low-dose 0.005 % estriol vaginal gel is safe and effective in preventing recurrent urinary tract infections in postmenopausal women with genitourinary syndrome of menopause, reducing the incidence and potentially decreasing the susceptibility to urogenital infections by improving vaginal pH. Study registration N°: 2018-001481-42. Date of registration: 09-04-2018.

MaturitasVol. 190
Madrid Institute for Advanced Studies (ES), Rafael Advanced Defense Systems (Israel) (IL), Principia Ingenieros Consultores (ES), Centro de Salud Casa del Barco (ES), Servicio Aragonés de Salud (ES), Unidad de Investigación en cuidados y servicios de salud (Investén-isciii) (ES), Hospital São Vicente (BR), Light Prescriptions Innovators (Spain) (ES), Departamento de Salud (ES), Centre for Plant Biotechnology and Genomics (ES)
Good health and well-being
Openalex Percentile: Top 13%
Urinary Tract Infections Management
1.93
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial — Juan Ignacio Martínez‐Salamanca, Eva García Aguilar, et al. · Maturitas (2024) | TGRS Research Map | TGRS